95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.61%
Revenue growth of 0.61% while OR is flat. Bruce Berkowitz would check if a small edge can widen further.
-0.39%
Negative gross profit growth while OR is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.39%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.39%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
21.86%
Net income growth above 1.5x OR's 7.51%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
18.18%
EPS growth above 1.5x OR's 10.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
18.18%
Diluted EPS growth above 1.5x OR's 10.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.48%
Share change of 0.48% while OR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.39%
Diluted share change of 0.39% while OR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-10.15%
Dividend reduction while OR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
4.99%
Positive OCF growth while OR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-6.13%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
238.75%
10Y CAGR of 238.75% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
241.38%
5Y CAGR of 241.38% while OR is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
10.52%
3Y CAGR of 10.52% while OR is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
110932.14%
OCF/share CAGR of 110932.14% while OR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
343.50%
OCF/share CAGR of 343.50% while OR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-1.33%
Negative 3Y OCF/share CAGR while OR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
1134.29%
10Y net income/share CAGR of 1134.29% while OR is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
242.41%
Net income/share CAGR of 242.41% while OR is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-24.60%
Negative 3Y CAGR while OR is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
3212.75%
Equity/share CAGR of 3212.75% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
186.70%
Equity/share CAGR of 186.70% while OR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
46.96%
Equity/share CAGR of 46.96% while OR is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-38.02%
Firm’s AR is declining while OR shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while OR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.20%
Negative asset growth while OR invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.91%
BV/share growth of 0.91% while OR is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-4.02%
We’re deleveraging while OR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-15.28%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.